# Phase 7AO Re-Analysis Validation Readiness

## 1. Purpose

Phase 7AO provides the consolidated validation and readiness layer for the Screen 3 backend re-analysis control plane block, covering Phase 7AJ through Phase 7AN and the Phase 7AO.1 missing metric / evidence availability model.

## 2. Scope

The scope is validation/readiness only: readiness metadata, validation scripts, readiness scripts, evidence availability checks, documentation, and tests for the 7AJ-7AO block.

## 3. Non-Goals

Phase 7AO does not execute analysis, call run_analysis.py, call object storage, read files, query DB, regenerate dashboards, mutate Phase 4I, alter diagnosis, alter scoring, alter recommendations, implement Screen 2 review workflow, implement active Screen 3 submit behavior, or implement Phase 8 sizing/TCO.

## 4. Re-Analysis Readiness

Re-analysis readiness confirms that boundary docs, source selection metadata, request metadata, controller/comparison metadata, preview-only UI, and missing metric handling are present and locally validated. Validation/readiness is not execution.

## 5. Validation Groups

The validation script reports these groups:

- reanalysis_boundary
- source_selection
- reanalysis_request
- reanalysis_controller
- screen3_action_ui
- reanalysis_readiness
- import_isolation
- runtime_safety
- documentation

## 6. Source Selection Validation

Source selection validation confirms that local, object storage, existing run, future upload, and future EM Extract source modes are metadata only. No object storage call, no file read, and no DB lookup occurs.

## 7. Request Validation

Request validation confirms that Screen 3 selected state, requested action, source selection linkage, actor metadata, execution mode metadata, and Phase 4I contract requirements are represented without execution.

## 8. Controller Validation

Controller validation confirms that execution plans/results remain metadata only. The controller does not call run_analysis.py, does not execute analysis, does not read files, does not call object storage, does not query DB, does not regenerate dashboards, and does not mutate Phase 4I.

## 9. Action UI Validation

Action UI validation confirms Screen 3 controls remain disabled/preview-only, with no backend execution, no active submit behavior, no fetch/XHR, no form POST, no run_analysis.py call, and no dashboard truth mutation.

## 10. Missing Metric / Evidence Availability Validation

Missing metric handling is validation only. It classifies supplied evidence metadata as available, missing, unavailable, unsupported, not_extracted, not_reliable, not_applicable, or unknown. It can recommend parser/source/scoring review, but it does not create candidates automatically and does not alter runtime confidence.

## 11. Runtime Safety Boundary

The readiness layer confirms:

- no backend execution
- no run_analysis.py call
- no object storage call
- no file read
- no DB lookup
- no Phase 4I mutation
- no dashboard regeneration
- no dashboard truth mutation

## 12. Phase 4I Boundary

Phase 4I remains authoritative and unmutated. Future re-analysis outputs must preserve or explicitly version the Phase 4I contract before they can be used.

## 13. Relationship to 7AJ

7AJ defined the Screen 3 backend re-analysis boundary. 7AO validates that boundary remains intact.

## 14. Relationship to 7AK

7AK defined the source selection model. 7AO validates source metadata readiness without loading sources.

## 15. Relationship to 7AL

7AL defined the backend re-analysis request model. 7AO validates request metadata and blocked execution flags.

## 16. Relationship to 7AM

7AM defined controller/comparison metadata. 7AO validates that the controller remains non-executing and that AWR/report comparison remains in-memory only.

## 17. Relationship to 7AN

7AN added disabled/preview-only Screen 3 action UI. 7AO validates that no active dashboard behavior is introduced.

## 18. Relationship to Future Screen 2 7AQ.1

Screen 2 evidence review model remains future 7AQ.1. Phase 7AO can recommend future evidence review, but it does not implement Screen 2 diagnostic review workflow.

## 19. Relationship to Phase 8

Future EM Extract and sizing/TCO belong to Phase 8. Phase 8 sizing/TCO is not implemented.

## 20. Acceptance Criteria

- Screen 3 re-analysis validation/readiness scripts exist.
- Missing metric/evidence availability handling exists for validation only.
- `screen3_reanalysis_ready=true` when focused checks pass.
- `missing_metric_handling_ready=true` when evidence model checks pass.
- No backend execution occurs.
- No run_analysis.py call occurs.
- No object storage call occurs.
- No file read occurs.
- No DB lookup occurs.
- No Phase 4I mutation occurs.
- Screen 2 evidence review model remains future 7AQ.1.
- Phase 8 sizing/TCO is not implemented.
